. Phase 3 trial for Moderna COVID-19 vaccine begins amid US summer surge - IOPAC Press "Enter" to skip to content

International Pathogen Surveillance Network announces first recipients of grants to better understand disease threats
- All WHO news
The World Health Organization (WHO) and partners announced 10 projects that will receive almost US$ 2 million in grants to...
The first-ever global oral health conference highlights universal health coverage by 2030
- All WHO news
Delegations from over 110 countries are coming together to produce national roadmaps and negotiate a joint declaration on oral health...
Lebanon: a conflict particularly destructive to health care
- All WHO news
Since 7 October 2023, 47% of attacks on health care – 65 out of 137 – have proven fatal to...

The right to health
- WHO Director-General speeches
Excellencies, ladies and gentlemen, Good afternoon, and thank you for having me. It’s a real honour to be with you...
Closing address at High-Level Action Day, First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Every human being is entitled to breathe clean air. It’s a human right. We are honoured to have the Human...
Opening address at the First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Excellency, second Lady Hajia Samira Bawumia of Ghana, my colleague colleague Dr Taalas, Secretary General of WMO and my sister...

Phase 3 trial for Moderna COVID-19 vaccine begins amid US summer surge

By iopac on July 27, 2020

Stephanie Soucheray | News Reporter | CIDRAP NewsJul 27, 2020The vaccine trial is starting against a backdrop of a vigorous US outbreak, in which three states outside the main hot spots reported record highs: Oklahoma, Missouri, and North Dakota.

Published in COVID-19

iopac

More from COVID-19More posts in COVID-19 »